tradingkey.logo
tradingkey.logo
Search

Krystal Biotech Inc

KRYS
Add to Watchlist
352.060USD
+16.870+5.03%
Close 07-27 16:00ETQuotes delayed by 15 min
10.28BMarket Cap
45.45P/E TTM

KRYS Financials

See Krystal Biotech Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Krystal Biotech Inc Earnings Date

Latest Release
Aug 3, 2026
EPS / Forecast
--/1.69
Revenue / Forecast
--/122.01M
Period
FY2025 Earnings
Revenue(YoY)
389.13M
33.94%
EPS(YoY)
7.08
126.94%
Analyst Rating
BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
54.00%1.91
11.70%1.77
189.61%2.74
143.57%1.33
3664.66%1.24
412.72%1.58
-67.13%0.95
143.70%0.54
101.87%0.03
124.72%0.31
--2.88
---1.25
---1.76
---1.25
---4.24
----
----
----
----
----
Revenue
31.95%116.36M
17.52%107.11M
16.65%97.80M
36.65%96.04M
94.88%88.18M
116.26%91.14M
879.91%83.84M
--70.28M
--45.25M
--42.14M
--8.56M
----
----
----
----
----
----
----
----
----
Net Profit
56.53%55.93M
13.02%51.40M
192.00%79.36M
146.23%38.33M
3734.01%35.73M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932.00K
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.30M
-46.99%-32.05M
-91.48%-29.85M
-71.78%-28.11M
-215.99%-49.97M
-110.02%-21.81M
-62.22%-15.59M
-139.47%-16.36M
Net Margin
18.63%48.07%
-3.83%47.99%
150.32%81.15%
80.19%39.91%
1867.37%40.52%
141.94%49.90%
-96.56%32.42%
--22.15%
--2.06%
--20.63%
--943.75%
----
----
----
----
----
----
----
----
----
Gross Margin
0.28%94.57%
-0.77%93.85%
3.93%95.64%
1.19%92.54%
-0.38%94.30%
1.48%94.57%
-5.51%92.03%
--91.45%
--94.65%
--93.19%
--97.39%
----
----
----
----
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
--0.00%
--0.00%
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Revenue
31.95%116.36M
17.52%107.11M
16.65%97.80M
36.65%96.04M
94.88%88.18M
116.26%91.14M
879.91%83.84M
--70.28M
--45.25M
--42.14M
--8.56M
----
----
----
----
----
----
----
----
----
Operating profit
48.41%53.69M
6.99%44.27M
18.44%41.37M
86.59%39.31M
522.03%36.18M
1218.64%41.38M
234.39%34.93M
155.37%21.07M
116.01%5.82M
109.02%3.14M
17.35%-25.99M
-32.33%-38.05M
-44.01%-36.32M
-58.95%-34.77M
-100.94%-31.45M
-75.40%-28.75M
-75.73%-25.22M
-109.94%-21.88M
-61.69%-15.65M
-135.73%-16.39M
Net Profit
56.53%55.93M
13.02%51.40M
192.00%79.36M
146.23%38.33M
3734.01%35.73M
423.23%45.48M
-66.34%27.18M
146.88%15.57M
102.06%932.00K
127.12%8.69M
370.51%80.75M
-18.15%-33.21M
9.34%-45.30M
-46.99%-32.05M
-91.48%-29.85M
-71.78%-28.11M
-215.99%-49.97M
-110.02%-21.81M
-62.22%-15.59M
-139.47%-16.36M
Current assets
32.99%1.02B
38.08%1.02B
29.79%925.65M
23.23%841.35M
27.32%766.80M
26.22%742.04M
22.51%713.16M
41.07%682.77M
69.44%602.25M
53.19%587.91M
46.42%582.13M
12.88%484.00M
-18.85%355.43M
-13.22%383.78M
14.97%397.58M
15.91%428.77M
7.93%438.00M
60.79%442.27M
20.22%345.81M
23.91%369.93M
Total current liabilities
35.62%107.80M
0.93%102.94M
1.94%91.27M
20.94%86.90M
67.03%79.49M
208.20%102.00M
224.57%89.53M
200.66%71.85M
35.67%47.59M
14.72%33.09M
-1.60%27.58M
-30.58%23.90M
-41.96%35.08M
12.09%28.85M
-21.65%28.03M
90.00%34.43M
560.95%60.44M
66.55%25.74M
397.07%35.78M
210.74%18.12M
Total assets
30.02%1.40B
26.33%1.33B
26.24%1.24B
24.05%1.14B
25.91%1.07B
29.02%1.06B
24.29%982.32M
34.16%917.66M
60.44%853.30M
46.54%818.36M
37.12%790.35M
13.75%684.03M
-13.78%531.85M
-10.83%558.45M
27.77%576.38M
35.57%601.32M
39.24%616.87M
101.48%626.29M
44.84%451.10M
39.42%443.56M
Total liabilities
33.98%120.24M
4.36%114.23M
5.96%102.22M
24.10%97.75M
66.02%89.74M
175.62%109.46M
180.43%96.47M
154.80%78.77M
27.84%54.05M
9.65%39.71M
-3.38%34.40M
-26.65%30.91M
-38.11%42.28M
10.70%36.22M
-16.92%35.61M
68.46%42.14M
452.48%68.32M
74.41%32.72M
340.43%42.86M
196.08%25.02M
Total equity
29.66%1.28B
28.87%1.22B
28.45%1.14B
24.05%1.04B
23.20%984.67M
21.54%946.38M
17.18%885.85M
28.45%838.89M
63.26%799.24M
49.10%778.64M
39.79%755.95M
16.80%653.11M
-10.75%489.57M
-12.02%522.23M
32.47%540.77M
33.60%559.18M
27.38%548.55M
103.22%593.58M
35.30%408.24M
35.15%418.54M
Net operating income
159.56%80.38M
46.68%77.51M
-32.62%39.66M
1365.09%52.73M
94.92%30.97M
830.68%52.84M
377.29%58.86M
87.81%-4.17M
160.74%15.89M
67.61%-7.23M
-7.81%-21.23M
20.60%-34.19M
-68.82%-26.16M
-6.84%-22.33M
-171.37%-19.69M
-325.11%-43.06M
-60.48%-15.49M
-160.47%-20.90M
-7.23%-7.25M
-100.42%-10.13M
Net investment
-16.09%-63.58M
113.32%11.16M
87.51%-4.29M
45.62%-10.53M
-110.81%-54.77M
-724.59%-83.78M
-132.63%-34.33M
-21.28%-19.35M
-829.16%-25.98M
-95.08%-10.16M
813.50%105.19M
58.25%-15.96M
106.37%3.56M
95.88%-5.21M
60.33%-14.74M
38.66%-38.22M
-7384.34%-55.91M
-1935.39%-126.54M
-1271.95%-37.17M
-6377.86%-62.32M
Net financing
16.10%-10.46M
545.22%15.67M
10.22%3.71M
-83.12%1.80M
-217.79%-12.47M
-7.29%2.43M
-74.87%3.37M
-94.26%10.64M
617.98%10.58M
-14.66%2.62M
531.51%13.39M
503.48%185.27M
371.96%1.47M
-98.48%3.07M
40.58%2.12M
15527.14%30.70M
-100.38%-542.00K
143213.48%202.07M
808.43%1.51M
-100.17%-199.00K

FAQs

What is the total revenue of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its total revenue reached 389.13M, with a year-on-year change of 290.51M.

What are the current assets of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its current assets were 1.02B, with a year-on-year change of 38.08.

What are the total assets of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its total assets of Krystal Biotech Inc were 1.33B, with a year-on-year change of 26.33.

What are the total liabilities of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its total liabilities of Krystal Biotech Inc were 114.23M, with a year-on-year change of 4.36.

What is the total equity of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its total equity of Krystal Biotech Inc was 1.22B, with a year-on-year change of 28.87.

What is the net operating income of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its net operating income of Krystal Biotech Inc was 161.29M, with a year-on-year change of 56.30.

What is the net investment of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its net investment of Krystal Biotech Inc was -58.42M, with a year-on-year change of 64.26.

What is the net financing of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its net financing of Krystal Biotech Inc was 8.71M, with a year-on-year change of -67.78.

What is the Earnings Per Share (EPS) of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 7.08, with a year-on-year change of 126.94.

What is the net income of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its net income was 204.83M, with a year-on-year change of 129.74.

What is the net margin of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its net profit margin was 52.64, with a year-on-year change of 71.52.

What is the gross margin of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its gross margin was 94.08, with a year-on-year change of 1.05.

What is the Return on Equity (ROE) of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its Return on Equity (ROE) was 18.91, with a year-on-year change of 82.97.

What is the Return on Assets (ROA) of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its Return on Assets (ROA) was 17.14, with a year-on-year change of 80.18.

What is the operating profit of Krystal Biotech Inc?

According to Krystal Biotech Inc's FY2025 earnings report, its operating profit was 161.29M, with a year-on-year change of 56.30.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.